National Institute Of Endocrinology C.I. Parhon — Clinical Trial Site

16 Registered trials

8 Currently recruiting

Organisation

National Institute Of Endocrinology C.I. Parhon

Location

Bucharest, Romania

Identifier

ORG-100046914

Address

Bulevardul Aviatorilor 34-38, 011863, Romania

Departments

#304: Endocrinology IV
Clinica Patologie Tiroidiana de Corelatie
Dept Endocrinology IV
Endocrinologie II "Patologia tiroidei de corelatie"
Endocrinology
Endocrinology I
Endocrinology II
Pediatric Endocrinology
Sectia Clinica de Endocrinologie II
Sectia Clinica de Endocrinologie IV
Sectia Clinica Patologie Tiroidiana de Corelatie
Sectia de Patologie Hipofizara si Neuroendocrina
Sectia Endocrinologie Pediatrica

Clinical trials at this site (16)

Search interface

A study of BMN 333 versus Vosoritide in Children with Achondroplasia Pending

2025-523811-12-00 Achondroplasia 10
A study to test the effects and safety of palopegteriparatide in adolescents with long-term hypoparathyroidism Recruiting

2025-523928-52-00 Chronic hypoparathyroidism 5 2026-04-22
A randomized, placebo-controlled trial to evaluate the safety and efficacy of Debio 4126 in patients with acromegaly previously treated with… Recruiting

2024-516616-24-00 Acromegaly 5 2025-07-23
Phase 3 Study of ALXN1850 in Treatment-Naïve Pediatric Participants with HPP Recruiting

2023-505675-73-00 hypophosphatasia 5 2024-04-26
EFFICACY AND SAFETY OF MET097 ONCE WEEKLY IN PEOPLE WITH OVERWEIGHT OR OBESITY AND TYPE 2 DIABETES (VESPER-5) Recruiting

2025-523975-48-00 Obesity 5 2026-05-08
Efficacy And Safety of MET097 Once Weekly In People With Overweight or Obesity (VESPER-4) Recruiting

2025-523974-18-00 Obesity 5 2026-04-30
A Phase 3 Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children with Short Statur… Recruiting

2025-523079-44-00 Turner Syndrome (TS) 5 2026-04-15
A Phase 3 Efficacy and Safety Study of Pitolisant in Patients with Prader-Willi Syndrome Recruiting

2023-508307-21-00 Prader-Willi syndrome 5 2025-03-19
Extension of a clinical trial to assess the safety of a study drug called "CORT125134" in the treatment of Cushing Syndrome Ended

2024-514079-17-00 Endogenous Cushing Syndrome 10 2020-05-28
Study of two different doses of cabozantinib in progressive, metastatic medullary thyroid cancer Ended

2024-516480-90-00 Metastatic Medullary Thyroid Cancer 6 2015-11-23
Phase 2 Study of ALXN2420 versus Placebo in Combination with Somatostatin Analogs in Participants with Acromegaly Halted

2025-521243-20-00 Acromegaly 4 2025-10-23
Once-weekly petrelintide versus placebo for obesity or overweight with comorbidities Ended

2024-512549-18-00 Weight management 4 2024-12-19
A study of efgartigimod PH20 SC given by prefilled syringe in adults with thyroid eye disease Ended

2023-509197-35-00 Thyroid Eye Disease (TED) 5 2024-10-17
SPI-62 as a treatment for adrenocorticotropic hormone-dependent Cushing’s syndrome Ended

2024-515913-17-00 Cushing's Syndrome 4 2024-10-10
This is a randomized, double-blinded, Placebo controlled trial that will evaluate the potential of tildacerfont to reduce glucocorticoid use… Ended

2023-503771-13-00 Classic Congenital Adrenal Hyperplasia 4 2021-01-28
This is a randomized, double-blinded, Placebo controlled trial with a 3-part treatment period that will evaluate the efficacy and safety of… Ended

2023-503770-21-00 Classic Congenital Adrenal Hyperplasia 4 2021-01-05